Results 1 to 10 of about 324,233 (319)
Ischemic Stroke in the Young [PDF]
Clinical and Applied Thrombosis/Hemostasis, 2021 The purpose of this article is to address several challenging questions in the management of young patients (those age 60 and under) who present with ischemic stroke. Do genetic thrombophilic states, strongly associated with venous thrombosis, independently cause arterial events in adults? Should cases of patent foramen ovale be closed with mechanical
Samuel A. Berkman, Shlee S. Song
openaire +4 more sources
Home Healthcare Now, 2016 Each year, more than 795,000 people in the United States suffer a stroke and by 2030, it is estimated that 4% of the U.S. population will have had a stroke. Home healthcare clinicians will be increasingly called upon to assist stroke survivors and their caregivers adjust to disability and assist the survivor during their reintegration into the ...
Teri, Capriotti, Teresa, Murphy
openaire +4 more sources
SUMOtherapeutics for Ischemic Stroke
Pharmaceuticals, 2023 Small, Ubiquitin-like Modifier (SUMO) is a post-translational modifier with a profound influence on several key biological processes including the mammalian stress response. Of particular interest is its neuroprotective effects, first recognized in the 13-lined ground squirrel (Ictidomys tridecemlineatus), in the context of hibernation torpor. Although
Paramesh Karandikar +9 more
openaire +5 more sources
Global Medical & Health Communication, 2023 Malnutrition in stroke patients can be caused by neurological deficits such as decreased consciousness, dysphagia, cranial nerve paresis, and hemiparesis/hemiplegia.
Lisda Amalia, Shafa Ayu Khairunnisa
doaj +1 more source
Research progress on the role of hormones in ischemic stroke
Frontiers in Immunology, 2022 Ischemic stroke is a major cause of death and disability around the world. However, ischemic stroke treatment is currently limited, with a narrow therapeutic window and unsatisfactory post-treatment outcomes.
Shuyuan Huang +6 more
doaj +1 more source
Interleukins and Ischemic Stroke [PDF]
Frontiers in Immunology, 2022 Ischemic stroke after cerebral artery occlusion is one of the major causes of chronic disability worldwide. Interleukins (ILs) play a bidirectional role in ischemic stroke through information transmission, activation and regulation of immune cells, mediating the activation, multiplication and differentiation of T and B cells and in the inflammatory ...
Hua Zhu +10 more
openaire +3 more sources
The Clinical Outcome Comparison of Ischemic Stroke with and without Ischemic Heart Disease [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018 Aim: Ischemic heart disease and stroke are the leading cause of morbidity and mortality worldwide. Ischemic stroke and ischemic heart disease have similar pathophysiological mechanisms and risk factors. Ischemic heart disease patients are associated with
Rizaldy Taslim Pinzon +1 more
doaj +1 more source
Frontiers in Pharmacology, 2023 Ischemic stroke has been a prominent focus of scientific investigation owing to its high prevalence, complex pathogenesis, and difficulties in treatment.
Lu Liu +12 more
doaj +1 more source
Risk Factors and Biomarkers of Ischemic Stroke in Cancer Patients [PDF]
Journal of Stroke, 2014 Background and PurposeStroke is common among cancer patients. However, risk factors and biomarkers of stroke in cancer patients are not well established.
Kwangsoo Kim, Ji-Hun Lee
doaj +1 more source
Risk factors for multiple recurrent ischemic strokes
Brain Circulation, 2023 BACKGROUND: Cardiovascular diseases, hypertension, diabetes mellitus, dyslipidemia, and atrial fibrillation are the most common modifiable risk factors for recurrent ischemic stroke.
Nevzat Uzuner, Gulnur Tekgol Uzuner
doaj +1 more source